Cited by 264Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and OutcomesPulmonary Hypertension Research and Treatments

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices

Open access

Alsafadi, Hani N., Staab-Weijnitz, Claudia A., Lehmann, Mareike, Lindner, Michael, Peschel, Britta, Königshoff, Melanie, Wagner, Darcy E.·2017·American Journal of Physiology-Lung Cellular and Molecular Physiology

DOI 10.1152/ajplung.00084.2017

Open this paper in CoChat — free account

Abstract

Idiopathic pulmonary fibrosis (IPF) is a devastating chronic interstitial lung disease (ILD) characterized by lung tissue scarring and high morbidity. Lung epithelial injury, myofibroblast activation, and deranged repair are believed to be key processes involved in disease onset and progression, but the exact molecular mechanisms behind IPF remain unclear. Several drugs have been shown to slow disease progression, but treatments that halt or reverse IPF progression have not been identified. Ex vivo models of human lung have been proposed for drug discovery, one of which is precision-cut lung slices (PCLS). Although PCLS production from IPF explants is possible, IPF explants are rare and typically represent end-stage disease. Here we present a novel model of early fibrosis-like changes in human PCLS derived from patients without ILD/IPF using a combination of profibrotic growth factors and signaling molecules (transforming growth factor-β, tumor necrosis factor-α, platelet-derived growth factor-AB, and lysophosphatidic acid). Fibrotic-like changes of PCLS were qualitatively analyzed by histology and immunofluorescence and quantitatively by water-soluble tetrazolium-1, RT-qPCR, Western blot analysis, and ELISA. PCLS remained viable after 5 days of treatment, and fibrotic gene expression ( FN1, SERPINE1, COL1A1, CTGF, MMP7, and ACTA2) increased as early as 24 h of treatment, with increases in protein levels at 48 h and increased deposition of extracellular matrix. Alveolar epithelium reprogramming was evident by decreases in surfactant protein C and loss of HOPX. In summary, using human-derived PCLS, we established a novel ex vivo model that displays characteristics of early fibrosis and could be used to evaluate novel therapies and study early-stage IPF pathomechanisms.

Integrity signals

Registry

Crossref · 10.1152/ajplung.00084.2017

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Idiopathic pulmonary fibrosis
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 820
Acellular Normal and Fibrotic Human Lung Matrices as a Culture System for In Vitro Investigation
Booth, A. J., Hadley, R., Cornett, A. M., Dreffs, A. A., Matthes, S. A., Tsui, J. L., Weiss, K., Horowitz, J. C., Fiore, V. F., Barker, T. H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0754oc · Cited by 665
Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
Xu, Y. J., Mizuno, T., Sridharan, A., Du, Y., Guo, M., Tang, J., Wikenheiser‐Brokamp, K. A., Perl, A. T., Funari, V. A., Gokey, J. J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90558 · Cited by 594
Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis
Georges, P. C., Hui, J.-J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., & Wells, R. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2007 · Cited by 577
Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis: From Innocent Targets to Serial Killers
Selman, M., & Pardo, A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-003tk · Cited by 528
The Compliance of Collagen Gels Regulates Transforming Growth Factor-β Induction of α-Smooth Muscle Actin in Fibroblasts
Arora, P. D., Narani, N., & McCulloch, C. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65334-5 · Cited by 474
Plasticity of Hopx(+) type I alveolar cells to regenerate type II cells in the lung
Jain, R., Barkauskas, C. E., Takeda, N., Bowie, E. J., Aghajanian, H., Wang, Q., Padmanabhan, A., Manderfield, L. J., Gupta, M., Li, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7727 · Cited by 303
WNT5A Is a Regulator of Fibroblast Proliferation and Resistance to Apoptosis
Vuga, L. J., Ben‐Yehudah, A., Kovkarova-Naumovski, E., Oriss, T. B., Gibson, K. F., Feghali‐Bostwick, C. A., & Kaminski, N. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0201oc · Cited by 215
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Mercer, P. F., Woodcock, H. V., Eley, J. D., Platé, M., Sulikowski, M. G., Durrenberger, P. F., Franklin, L., Nanthakumar, C. B., Man, Y., Genovese, F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207429 · Cited by 206

Show all 21 references

Sorted by citations

Items 101–200 of 264

Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy
Oakley, F., Gee, L., Sheerin, N., & Borthwick, L. A. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.10.004 · Cited by 17
Silencing Heat Shock Protein 47 (HSP47) in Fibrogenic Precision-Cut Lung Slices: A Surprising Lack of Effects on Fibrogenesis?
Ruigrok, M. J. R., Amasi, K. E., Leeming, D. J., Sand, J. M. B., Frijlink, H. W., Hinrichs, W. L. J., & Olinga, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.607962 · Cited by 17
Comparing species-different responses in pulmonary fibrosis research: Current understanding of in vitro lung cell models and nanomaterials
Keshavan, S., Bannuscher, A., Drašler, B., Barošová, H., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106387 · Cited by 16
Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts’ response to fibrotic growth factors
Madsen, S. F., Sand, J. M. B., Juhl, P., Karsdal, M. A., Thudium, C. S., Siebuhr, A. S., & Bay‐Jensen, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-36416-6 · Cited by 19
Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling
Gerckens, M., Alsafadi, H. N., Wagner, D. E., Lindner, M., Burgstaller, G., & Königshoff, M. (2019) · Journal of Visualized Experiments · doi:10.3791/58437-v · Cited by 16
Self-citation
MicroRNA-1 protects the endothelium in acute lung injury
Korde, A., Haslip, M., Pednekar, P., Khan, A., Chioccioli, M., Mehta, S. S., López‐Giráldez, F., Bermejo, S. D., Rojas, M. M., Cruz, C. S. D., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164816 · Cited by 16
Perlin noise generation of physiologically realistic cardiac fibrosis
Lawson, B., Drovandi, C., Burrage, P., Bueno‐Orovio, A., dos Santos, R. W., Rodríguez, B., Mengersen, K. L., & Burrage, K. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103240 · Cited by 27
The acid injury and repair (AIR) model: A novel ex-vivo tool to understand lung repair
Kim, S. Y., Mongey, R., Wang, P., ROTHERY, S. M., Gaboriau, D. C. A., Hind, M. D., Griffiths, M., & Dean, C. H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120480 · Cited by 15
In Vitro Modeling of Idiopathic Pulmonary Fibrosis: Lung-on-a-Chip Systems and Other 3D Cultures
Corona, C., Man, K., Newton, C. A., Nguyen, K. T., & Yang, Y. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111751 · Cited by 13
FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis
Ghanem, M., Archer, G., Justet, A., Jaillet, M., Vasarmidi, E., Mordant, P., Castier, Y., Mal, H., Cazes, A., Poté, N., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202311-2021oc · Cited by 16
Lung organoids and other preclinical models of pulmonary fibrosis
Oglesby, I. K., Schweikert, A., Fox, B., Redmond, C., Donnelly, S. C., & Hurley, K. (2021) · QJM · doi:10.1093/qjmed/hcaa281 · Cited by 14
Catch your breath: The protective role of the angiotensin AT2 receptor for the treatment of idiopathic pulmonary fibrosis
Young, O. N., Bourke, J. E., & Widdop, R. E. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115839 · Cited by 16
N-acetyl cysteine protects against chlorine-induced tissue damage in an ex vivo model
Ågren, L., Elfsmark, L., Akfur, C., Hägglund, L., Ekstrand‐Hammarström, B., & Jonasson, S. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.01.006 · Cited by 14
M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy
Zheng, S., Zhou, Z., Ji, J., Liu, Y., Jiao, X., Li, X., Shen, Y., Hong, H., & Han, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113862 · Cited by 16
The dawn of the omics era in human precision-cut lung slices
Stegmayr, J., & Wagner, D. E. (2021) · European Respiratory Journal · doi:10.1183/13993003.00203-2021 · Cited by 12
Self-citation
Variations in mechanical stiffness alter microvascular sprouting and stability in a PEG hydrogel model of idiopathic pulmonary fibrosis
Leonard‐Duke, J., Bruce, A. C., Peirce, S. M., & Taite, L. J. (2023) · Microcirculation · doi:10.1111/micc.12817 · Cited by 14
Alveolar epithelial cell plasticity and injury memory in human pulmonary fibrosisPreprint
Adams, T. S., Schupp, J. C., Balayev, A., Khoury, J., Justet, A., Nikola, F., Sadeleer, L. D., Cala-García, J., Zapata‐Ortega, M., Benos, P. V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.658504 · Cited by 16
Self-citation
Advanced 3D In Vitro Lung Fibrosis Models: Contemporary Status, Clinical Uptake, and Prospective Outlooks
Jain, N., Bhushan, B. L. S., Natarajan, M., Mehta, R., Saini, D. K., & Chatterjee, K. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01499 · Cited by 13
Perlin Noise Generation of Physiologically Realistic Patterns of FibrosisPreprint
Jakes, D., Burrage, K., Drovandi, C., Burrage, P., Bueno‐Orovio, A., dos Santos, R. W., Rodríguez, B., & Lawson, B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/668848 · Cited by 12
Targeting alveolar epithelial cell metabolism in pulmonary fibrosis: Pioneering an emerging therapeutic strategy
Dai, T., Liang, Y., Li, X., Zhao, J., Li, G., Li, Q., Xu, L., & Zhao, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1608750 · Cited by 11
Living human lung slices for ex vivo modelling of lung cancer
Mansouri, S., Karger, A., Ruppert, C., Schneider, M. A., Weigert, A., Nandigama, R., Aliraj, B., Strotmann, L., Cherian, A. V., Pruefer, D., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.190703 · Cited by 11
The Fibrotic Phenotype of Human Precision-Cut Lung Slices Is Maintained after Cryopreservation
Marimoutou, M., Patel, V., Kim, J. H., Schaible, N., Alvarez, J., Hughes, J., Obermok, M., Rodríguez, C. I., Kallarakkal, T. G., Suki, B., et al. (2024) · Toxics · doi:10.3390/toxics12090637 · Cited by 11
Cyclic GMP-AMP synthase expression is enhanced in systemic sclerosis-associated interstitial lung disease and stimulates inflammatory myofibroblast activation
Yu, S., Hu, B., Sun, Y. S., Peng, X. Y., Lee, C., Woo, S., McGovern, J., Zielonka, J., Saber, T., Ghincea, A., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.01564-2024 · Cited by 12
Precision-cut lung slices as an ex vivo model to study Pneumocystis murina survival and antimicrobial susceptibility
Munyonho, F. T., Clark, R. D. E., Lin, D., Khatun, M. S., Pungan, D., Dai, G., & Kolls, J. K. (2023) · mBio · doi:10.1128/mbio.01464-23 · Cited by 11
An American Physiological Society cross-journal Call for Papers on “Deconstructing Organs: Single-Cell Analyses, Decellularized Organs, Organoids, and Organ-on-a-Chip Models”
Adams, J. C., Bell, P. D., Bodine, S. C., Brooks, H. L., Bunnett, N. W., Joe, B., Keehan, K. H., Kleyman, T. R., Marette, A., Morty, R. E., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00311.2020 · Cited by 11
Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B
Flaxman, H. A., Chrysovergi, M.-A., Han, H., Kabir, F., Lister, R. T., Chang, C., Yvon, R., Black, K. E., Weigert, A., Savai, R., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.171162 · Cited by 13
The novel lysophosphatidic acid receptor 1-selective antagonist, ACT-1016-0707, has unique binding properties that translate into effective antifibrotic and anti-inflammatory activity in different models of pulmonary fibrosis
Birker, M., Boucher, M., Ranieri, G., Poirey, S., Studer, R. O., Freti, D., Schnoebelen, M., Froidevaux, S., Morrison, K., Wyss, C., et al. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103396 · Cited by 11
Prolonged airway explant culture enables study of health, disease, and viral pathogenesis
Lee, R. E., Okuda, K., Galiger, J. R., Schworer, S. A., Rogers, T. D., Dang, H., Gilmore, R. C., Edwards, C. E., Crisp, G., Nakano, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adp0451 · Cited by 10
Lung Organotypic Slices Enable Rapid Quantification of Acute Radiotherapy Induced Toxicity
Dubail, M., Heinrich, S., Portier, L., Bastian, J., Giuliano, L., Aggar, L., Berthault, N., Londoño‐Vallejo, A., Vilalta, M., Boivin, G., et al. (2023) · Cells · doi:10.3390/cells12202435 · Cited by 10
The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation
Kortekaas, R. K., Geillinger‐Kästle, K. E., Fuentes‐Mateos, R., Schoenleber, A., van der Koog, L., Elferink, R. A. B., Al‐Alyan, N., Burgess, J. K., & Gosens, R. (2024) · The FASEB Journal · doi:10.1096/fj.202302405rr · Cited by 11
Epithelial outgrowth through mesenchymal rings drives lung alveologenesis
Negretti, N. M., Son, Y., Crooke, P. S., Plosa, E. J., Benjamin, J. T., Jetter, C. S., Bunn, C., Mignemi, N. A., Marini, J. J., Hackett, A. N., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187876 · Cited by 9
Fibrosis in PCLS: comparing TGF-β and fibrotic cocktail
Machahua, C., Marti, T. M., Dorn, P., & Funke-Chambour, M. (2025) · Respiratory Research · doi:10.1186/s12931-025-03110-2 · Cited by 11
Engineered hydrogel biomaterials facilitate lung progenitor cell differentiation from induced pluripotent stem cells
Tanneberger, A. E., Blomberg, R., Bilousova, G., Ryan, A. L., & Magin, C. M. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00419.2024 · Cited by 10
The role of vascularity and the fibrovascular interface in interstitial lung diseases
Dietrich, J., Kang, A., Tielemans, B., Verleden, S. E., Khalil, H. A., Länger, F. P., Bruners, P., Mentzer, S. J., Welte, T., Dreher, M., et al. (2025) · European Respiratory Review · doi:10.1183/16000617.0080-2024 · Cited by 12
Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor–CD74 signaling
Kim, S., Nouws, J., Ruwisch, J., Woodard, G. A., Cooley, J. C., Khoury, J., Sun, H., Doherty, E. H., Piecychna, M., Manning, E. P., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr2277 · Cited by 9
Pulmonary endogenous progenitor stem cell subpopulation: Physiology, pathogenesis, and progress
Liu, D., Xu, C., Jiang, L., & Zhu, X. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.08.005 · Cited by 10
Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
Miura, Y., Ohkubo, H., Nakano, A., Bourke, J. E., & Kanazawa, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028613 · Cited by 9
Untargeted metabolomics reveals that declined PE and PC in obesity may be associated with prostate hyperplasia
Fan, G., Guan, X., Guan, B., Zhu, H., Pei, Y., Jiang, C., Xiao, Y., Li, Z., & Cao, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301011 · Cited by 10
Comparative Proteomic Analysis of Liver Steatosis and Fibrosis after Oral Hepatotoxicant Administration in Sprague-Dawley Rats
McDyre, B. C., AbdulHameed, M. D. M., Permenter, M. G., Dennis, W. E., Baer, C. E., Koontz, J. M., Boyle, M. H., Wallqvist, A., Lewis, J. A., & Ippolito, D. L. (2018) · Toxicologic Pathology · doi:10.1177/0192623317747549 · Cited by 9
Uncovering the cytotoxic effects of air pollution with multi-modal imaging of in vitro respiratory models
Al‐Rekabi, Z., Dondi, C., Faruqui, N., Siddiqui, N. S., Elowsson, L., Rissler, J., Kåredal, M. H., Mudway, I., Larsson‐Callerfelt, A., & Shaw, M. (2023) · Royal Society Open Science · doi:10.1098/rsos.221426 · Cited by 9
Evaluation of an ex vivo fibrogenesis model using human lung slices prepared from small tissues
Sun, Y. C., Jing, P., Gan, H., Wang, X., Zhu, X., Fan, J., Li, H., Zhang, Z., Lin, J. C. J., & Gu, Z. (2023) · European journal of medical research · doi:10.1186/s40001-023-01104-8 · Cited by 7
Cold storage of human precision-cut lung slices in TiProtec preserves cellular composition and transcriptional responses and enables on-demand mechanistic studies
Melo-Narváez, M. C., Gölitz, F., Jain, E., Gote-Schniering, J., Stoleriu, M. G., Bertrams, W., Schmeck, B., Yildirim, A. Ö., Rauen, U., Wille, T., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03132-w · Cited by 8
Self-citation
Biomaterial-based 3D human lung models replicate pathological characteristics of early pulmonary fibrosis
Tanneberger, A. E., Blomberg, R., Kary, A. D., Lu, A., Riches, D. W. H., & Magin, C. M. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.08.010 · Cited by 8
Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe Chronic Obstructive Pulmonary Disease
Khalenkow, D., Brandsma, C., Timens, W., Choy, D. F., Grimbaldeston, M. A., Rosenberger, C. M., Slebos, D., Kerstjens, H. A. M., Faiz, A., Koppelman, G. H., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0296oc · Cited by 8
JUNB O‐GlcNAcylation‐Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis
Bammert, M., Ansari, M., Haag, L., Ahmad, Z., Schröder, V., Birch, J., Santacruz, D., Rust, W., Viollet, C., Strobel, B., et al. (2024) · Advanced Science · doi:10.1002/advs.202406751 · Cited by 8
Infection of Human Precision-Cut Lung Slices with the Influenza Virus
Sewald, K., & Danov, O. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2364-0_9 · Cited by 8
Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine
Jeong, M. H., Han, H., Lagares, D., & Im, H. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00028 · Cited by 10
Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models
Cardona-Timoner, M., Gomes, R. N., & Nascimento, D. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073038 · Cited by 9
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly
Ocaña, S. C., El-Merhie, N., Kuipers, M. E., Lehmann, M., Enes, S. R., Voss, C., Dean, L. S. N., Loxham, M., Boots, A. W., Cloonan, S. M., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00561-2022 · Cited by 8
Self-citation
The Application of New Approach Methodologies in Respiratory Disease Research: Their Role in Improving Translational Medicine from Bench to Bedside
da Silva, A. C. G., & Valadares, M. C. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231170392 · Cited by 7
WNT5A in Extracellular Vesicles. A New Frontier for Pulmonary Fibrosis
Ahangari, F., & Kaminski, N. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1321ed · Cited by 7
Precision Cut Lung Slices as a Model for 3R Application in Toxicology
Herbert, J. J., & Gow, A. J. (2020) · Applied In Vitro Toxicology · doi:10.1089/aivt.2020.29025.com · Cited by 7
SenSet, a novel human lung senescence cell gene signature, identifies cell-specific senescence mechanismsPreprint
Hasanaj, E., Beaulieu, D., Wang, C., Hu, Q., Bueno, M., Sembrat, J., Pineda, R., Melo-Narváez, M. C., Cárdenes, N., Yanwu, Z., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.21.629928 · Cited by 7
Self-citation
Dehydrocorydaline attenuates bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation
He, J., Yue, H., Zhang, S., Dong, R., Zhang, F., Wang, X., Wang, K., Zhang, H., Yang, D., Dong, Z., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03218-5 · Cited by 6
Fungal infections in focus: accelerating non-invasive imaging from preclinical insights to clinical breakthroughs
Michiels, L., Shameem, M., Vanhoffelen, E., Reséndiz-Sharpe, A., Johnston, S. A., Bézière, N., & Velde, G. V. (2025) · npj Imaging · doi:10.1038/s44303-025-00105-y · Cited by 7
Altered Metabolism in Idiopathic Pulmonary Fibrosis
Callaghan, N. I., & Huyer, L. D. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70112 · Cited by 6
Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 6
Self-citation
Three-Dimensional Idiopathic Pulmonary Fibrosis Model Using a Layer-by-Layer Cell Coating Technique
Kuno, H., Akagi, T., Fukui, E., Yamato, H., Akashi, M., & Shintani, Y. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0365 · Cited by 6
Angiotensin-Converting Enzyme 2 Inhibits Lipopolysaccharide-Caused Lung Fibrosis via Downregulating the Transforming Growth Factor β-1/Smad2/Smad3 Pathway
Lin, X., Lin, W., Zhuang, Y., & Gao, F. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000907 · Cited by 6
Anti-fibrotic strategies and pulmonary fibrosis
Gunatilaka, A., Zhang, S., Tan, W. S. D., & Stewart, A. G. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.04.002 · Cited by 7
A method for TAT-Cre recombinase-mediated floxed allele modification in ex vivo tissue slices
Cheong, S., Luis, T. C., Stewart, M. E., Hillier, R., Hind, M. D., & Dean, C. H. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050267 · Cited by 6
Unagi: Deep Generative Model for Deciphering Cellular Dynamics and In-Silico Drug Discovery in Complex Diseases
Zheng, Y., Schupp, J., Adams, T., Clair, G., Justet, A., Ahangari, F., Yan, X., Hansen, P., Carlon, M., Cortesi, E., et al. (2023) · doi:10.21203/rs.3.rs-3676579/v1 · Cited by 34
Self-citation
Inhalable lipid nanoparticles for macrophage-specific STING gene editing to ameliorate pulmonary fibrosis
Wang, Y., Liu, X., Xuan, W., Huang, W., Zhu, Y., Mao, C., & Liu, Y. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.003 · Cited by 7
Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
Li, X., Xue, D., Wei, Q., & Tan, X. (2025) · Immunobiology · doi:10.1016/j.imbio.2024.152866 · Cited by 5
Increased thermal stability of FGF10 leads to ectopic signaling during development
Czyrek, A. A., Baran, K., Hrubá, E., Horáčková, A., Bosáková, V., Chudzian, J., Fafílek, B., Laskova, V., Štěpánková, V., Bednář, D., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05681-1 · Cited by 5
Inhibition of DLK1 regulates AT2 differentiation and alleviates established pulmonary fibrosis by upregulating TTF-1/CLDN6
Li, Y., Zhou, C., Sun, J., Wang, E., Wang, C., Liu, X., Zhou, X., & Bai, J. (2025) · Respiratory Research · doi:10.1186/s12931-025-03264-z · Cited by 5
The epithelium takes the stage in asthma and inflammatory bowel diseases
López-Posadas, R., Bagley, D., Pardo-Pastor, C., & Zapater, E. O. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1258859 · Cited by 5
Comparative metabolomic analysis of human lung slices (hu-PCLS) exposed to either standard or FLASH protons: a pilot study
Velalopoulou, A. P., Mak, T. D., Deziel, A., Kim, M. M., Koumenis, C., Christofidou‐Solomidou, M., & Laiakis, E. C. (2025) · Radiation Oncology · doi:10.1186/s13014-025-02714-8 · Cited by 4
Autologous precision-cut lung slice co-culture models for studying macrophage-driven fibrosis
Chang, S.-Y., Chang, W., Yang, D. C. H., Hong, Q.-S., Hsu, S., Wu, R., & Chen, C. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1526787 · Cited by 5
Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosis
Lynch, J. P., Organ, L. A., Tomusange, K., Kowalczyk, L., Hartman, D. J., Tester, A. M., Hosking, C. G., & Foley, M. (2025) · mAbs · doi:10.1080/19420862.2025.2505090 · Cited by 4
Label-free four-dimensional live imaging of immune–stromal interactions in human alveolar tissue using higher harmonic generation microscopy
Ma, Y., Lubbersen, N. B., Spies, S., Dijkhuis, A., van Dorp, M., Dickhoff, C., Annema, J. T., Duitman, J., & Groot, M. L. (2025) · European Respiratory Journal · doi:10.1183/13993003.01530-2025 · Cited by 4
The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
Liu, M., Cheng, Z. J., Xue, M., Lin, R., Zhang, T., & Sun, B. (2023) · Precision Medical Sciences · doi:10.1002/prm2.12106 · Cited by 5
Causal relationship between serum metabolites and idiopathic pulmonary fibrosis: Insights from a two-sample Mendelian randomization study
Zou, Q., Hu, J.-P., Cao, Y., She, C., Liang, L., & Liu, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36125 · Cited by 4
Embracing multiple infection models to tackle Q fever: A review of in vitro, in vivo, and lung ex vivo models
Guzman, R. M., & Voth, D. E. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104880 · Cited by 4
Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis
Pierre, L. S., Berhan, A., Sung, E. K., Alvarez, J. R., Wang, H., Ji, Y., Liu, Y., Yu, H. V., Meier, A., Afshar, K., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167572 · Cited by 4
A novel ex vivo approach for investigating profibrotic macrophage polarization using murine precision-cut lung slices
Vierhout, M., Ayoub, A., Ali, P., Kumaran, V. R., Naiel, S., Isshiki, T., Koenig, J. F. E., Kolb, M. R. J., & Ask, K. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151038 · Cited by 5
Ex vivo tissue perturbations coupled to single cell RNA-seq reveal multi-lineage cell circuit dynamics in human lung fibrogenesisPreprint
Lang, N. J., Gote-Schniering, J., Porras-Gonzalez, D., Yang, L., Sadeleer, L. D., Jentzsch, R. C., Shitov, V. A., Zhou, S., Ansari, M., Agami, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.524219 · Cited by 4
Assessment of Collagen in Translational Models of Lung Research
Staab-Weijnitz, C. A., Onursal, C., Nambiar, D., & Vanacore, R. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-26625-6_11 · Cited by 3
Self-citation
The LPAR1 antagonist, PIPE-791 produces antifibrotic effects in models of lung fibrosis
Poon, M. M., Lorrain, K. I., Broadhead, A. R., Stebbins, K. J., Bagnol, D., Edu, G. C., Joseph, G. U., Baccei, C. S., Roppe, J. R., Schrader, T. O., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03340-4 · Cited by 3
Insight into the pathogenesis of interstitial lung diseases and near-to-native lung fibrosis models
Štefániková, M., Sedláková, V., Portakal, T., Hampl, A., Vaňhara, P., & Doubková, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-03504-4 · Cited by 3
Emerging concepts and novel mechanisms in organ fibrosis
Ruiz‐Villalba, A., & Pardo–Saganta, A. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00446-7 · Cited by 5
Chemical warfare agent research in precision‐cut tissue slices—a useful alternative approach
Herbert, J. J., Laskin, D. L., Gow, A. J., & Laskin, J. D. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14459 · Cited by 3
A Novel Method for Floxed Gene Manipulation Using TAT-Cre Recombinase in Ex Vivo Precision-Cut Lung Slices (PCLS)
Cheong, S., Luis, T. C., Hind, M. D., & Dean, C. H. (2024) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4980 · Cited by 3
Cryopreservation of human lung tissue for 3D ex vivo analysis
Diodati, N. G., Qu, G., Mehrad, B., & Schaller, M. A. (2025) · Respiratory Research · doi:10.1186/s12931-025-03265-y · Cited by 3
Sanglifehrin A mitigates multi-organ fibrosis in vivo by inducing secretion of the collagen chaperone cyclophilin BPreprint
Flaxman, H. A., Chrysovergi, M.-A., Han, H., Kabir, F., Lister, R. T., Chang, C., Black, K. E., Lagares, D., & Woo, C. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.09.531890 · Cited by 3
A Nerve-Fibroblast Axis in Mammalian Lung FibrosisPreprint
Ishikawa, G., Peng, X., Ghincea, A., McGovern, J., Zielonka, J., Jeevanandam, A., Shao, S., Woo, S., Okuno, D., Yu, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.09.611003 · Cited by 3
Peptidomic and proteomic analysis of precision-cut lung slice supernatants
Hansen, A. H., Lorentzen, L. G., Leeming, D. J., Sand, J. M. B., Hägglund, P., & Davies, M. J. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115837 · Cited by 2
Identification of early genes in the pathophysiology of fibrotic interstitial lung disease in a new model of pulmonary fibrosis
Hennion, N., Bedart, C., Vandomber, L., Gottrand, F., Humez, S., Chenivesse, C., Desseyn, J., & Gouyer, V. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05620-0 · Cited by 2
Insights from precision-cut lung slices—investigating mechanisms and therapeutics for pulmonary hypertension
Studley, W., Lamanna, E., Nold‐Petry, C. A., Qin, C. X., & Bourke, J. E. (2025) · Respiratory Research · doi:10.1186/s12931-025-03290-x · Cited by 2
NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β‐TrCP1/FBXO5 Axis
Tong, Y., Lear, T., Tuncer, F., Villandre, J. J., Boudreau, Á. N., Lin, B., Alfaras, I., Kennerdell, J. R., Camarco, D. P., Larsen, M. B., et al. (2025) · Advanced Science · doi:10.1002/advs.202500798 · Cited by 2
TGF-β coordinates alanine synthesis and import for myofibroblast differentiation in pulmonary fibrosis
Li, F., Vigder, N., Ziehr, D. R., Kamiya, M., Nguyen, H. N., Faustino, D. E. F., Khalil, A. H., Lam, H. C., Steinhauser, M. L., Kim, E. Y., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.199449 · Cited by 2
SIK2 Drives Pulmonary Fibrosis by Enhancing Fibroblast Glycolysis and Activation
He, J., Dong, R., Yue, H., Zhang, F., Dou, X., Li, X., Li, H., & Zhang, H. (2025) · Biomedicines · doi:10.3390/biomedicines13081919 · Cited by 2
LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slices from patients with IPF
MacKenzie, B., Mahavadi, P., Pinho Jannini-Sa, Y. A., Creyns, B., Coelho, A. L., Espindola, M., Ruppert, C., Windsor, B., Aigner, C., Hogaboam, C. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113437 · Cited by 2
Modulation of an aberrant basal cell program in human alveolar epithelial spheroids and lung slices
Li, Y., Wellmerling, J. H., Rosas, L., Link, P. A., Chow, D., Alvarez, J., Choi, K. M., Espinosa, A. M. D., Gilbert, R. M., Goplen, N., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03441-0 · Cited by 3
Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research
Putman, M. S., Hull-Meichle, R. L., Waters, S. A., Tuggle, K. L., Sommer, P., Conway, R., Borthwick, L. A., Knudsen, J. G., Dean, E. D., Stanley, S. A., et al. (2026) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2026.03.021 · Cited by 2
SenSet defines cell-type specific senescence signatures in the aged human lung
Hasanaj, E., Beaulieu, D., Wang, C., Hu, Q., Rosas, L., Bueno, M., Sembrat, J., Pineda, R., Melo-Narváez, M. C., Cárdenes, N., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00762-8 · Cited by 11
Self-citation
An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis
Matralis, A. N., Stylianaki, E.-A., Ladopoulou, E. M., Kanellopoulou, P., Smyrniotis, S., Magkrioti, C., Papavasileiou, K. D., Willems, S., Pabon, J. P. R., Nastos, D., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102778 · Cited by 2
An evaluation of an open access iPSC training course: “How to model interstitial lung disease using patient-derived iPSCs”
Schweikert, A., Kenny, S., Oglesby, I. K., Glasgow, A. M. A., Santi, C. D., Gensch, I., Lachmann, N., Desroziers, T., Fletcher, C., Snijders, D., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03598-9 · Cited by 2
A human PCLS model of lung injury and repair for discovery and pharmaceutical research
Bankole, E., Wong, C. W., Kim, S. Y., Hind, M. D., & Dean, C. H. (2025) · Respiratory Research · doi:10.1186/s12931-025-03314-6 · Cited by 2
3D modeling of the lung in health and disease
Surolia, R., Dsouza, K. G., & Antony, V. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824064-9.00016-2 · Cited by 2

Authors: Alsafadi, H. N., Staab-Weijnitz, C. A., Lehmann, M., Lindner, M., Peschel, B., Königshoff, M., & Wagner, D. E.
Affiliations: Helmholtz Munich (DE)
Asklepios Fachkliniken München-Gauting (DE)
Helmholtz Zentrum Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany;
Corresponding author: Wagner, Darcy E.
ORCID: Alsafadi, Hani N.
Staab-Weijnitz, Claudia A.
Lehmann, Mareike
Lindner, Michael
Königshoff, Melanie
Wagner, Darcy E.
Venue: American Journal of Physiology-Lung Cellular and Molecular Physiology
Publisher: American Physiological Society
Published: 2017-06-01
Volume: 312
Issue: 6
Pages: L896-L902
ISSN: 1040-0605 (ISSN-L)
1522-1504
DOI: 10.1152/ajplung.00084.2017
OpenAlex: W2595866898
Cited by: 263
References: 21
Citations by year: 2026: 25 · 2025: 52 · 2024: 39 · 2023: 41 · 2022: 25 · 2021: 24 · 2020: 19 · 2019: 21 · 2018: 14 · 2017: 3
FWCI: 12.79
Type: journal article
Language: en
Open access: green
push-zb.helmholtz-muenchen.de
Licence: other-oa
Locations: American Journal of Physiology-Lung Cellular and Molecular Physiology (publishedVersion)
PubMed (publishedVersion)
Lund University Publications (Lund University) (submittedVersion)
Site cant be reached (submittedVersion, other-oa)
Funders: American Thoracic Society (ATS)
Helmholtz Zentrum München GmbH
Whitaker International Fellows and Scholars Program
Helmholtz Association
EC | European Research Council (ERC) (ERC-2010-StG 261302)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords: idiopathic pulmonary fibrosis, precision-cut lung slices, ex vivo model, fibrosis, TGF-beta, TNF-α, PDGF-AB, lysophosphatidic acid, myofibroblast activation, extracellular matrix deposition, surfactant protein C, HOPX, interstitial lung disease
MeSH terms: Aged, Extracellular Matrix, Female, Humans, Lung, Male, Models, Biological, Tissue Survival, Biomarkers, Up-Regulation, Inflammation Mediators, Collagen Type I, Idiopathic Pulmonary Fibrosis, Alveolar Epithelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks